Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease

Duong N, Lee JY, Peprah Y, Brown T, Linder JA, Doctor JN, Meeker D, Fox CR, Goldstein NJ, Persell SD, Petito LC. Changing Clinician Behavior[...]

Benjamin LN, Núñez ER, Chen L, Motwani Y, Yuan A, Vangala S, Slatore CG, Wiener RS, Elashoff DA, Yano EM, Washington DL, Mangione CM. Centralization[...]

Parikh ND, Liu CC, DeMaio M, Yeh AH, Stackpole ML, Li S, Agopian VG, Li W, Zhou XJ, Ni X, Lok AS, Han SB. Methylation[...]